Answers are grounded in this paper and cite their sources.
Experimental evaluation shows lercanidipine improves kidney function in rats affected by gentamicin, indicating protective benefits.
A BSTRACT Gentamicin, an aminoglycoside antibiotic, induces nephrotoxicity mainly through oxidative stress. This study evaluated the nephroprotective potential of lercanidipine, a calcium-channel blocker, against gentamicin-induced renal injury in rats. Adult Sprague–Dawley rats were randomly divided into four groups: control, lercanidipine (3 mg/kg/day, p.o.), gentamicin (50 mg/kg/day, i.m.), and a combination group pretreated with lercanidipine for 5 days followed by concurrent gentamicin for 5 days. Serum urea, creatinine, sodium (Na + ), and potassium (K + ) were determined, and kidney homogenates were analyzed for malondialdehyde (MDA), glutathione (GSH), and superoxide dismutase (SOD). Gentamicin treatment produced marked renal dysfunction, with elevated serum urea and creatinine, increased Na + by 29%, and decreased K + by 27.5% relative to control, accompanied by a 37% reduction in urine volume. Co-treatment with lercanidipine restored electrolyte balance, lowering Na + by 20% and raising K + by 27% compared with gentamicin alone, while increasing urine volume by 42%. Lercanidipine also markedly attenuated oxidative stress, reducing MDA by about 65% and increasing SOD and GSH activities by approximately 183% and 140%, respectively, relative to gentamicin alone. These findings demonstrate that lercanidipine significantly protects against gentamicin-induced nephrotoxicity by improving renal function, restoring electrolyte homeostasis, and enhancing the antioxidant defence system.
No takes yet. Share an insight, caveat, or question.
Shubbar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: